Previous Article | Next Article ![]()
Journal of Clinical Microbiology, April 2001, p. 1586-1590, Vol. 39, No. 4
Meningitis and Special Pathogens Branch,
Division of Bacterial and Mycotic Diseases, National Center for
Infectious Diseases,1 and Epidemiology
and Surveillance Division, National Immunization
Program,3 Centers for Disease Control and
Prevention, Public Health Service, U.S. Department of Health and Human
Services, Atlanta, Georgia, and Laboratory Services Branch,
Ontario Ministry of Health, Toronto, Canada2
Received 12 July 2000/Returned for modification 26 September
2000/Accepted 13 January 2001
Molecular characterization of 53 U.S. and Canadian
Corynebacterium diphtheriae isolates by multilocus enzyme
electrophoresis, ribotyping, and random amplified polymorphic DNA
showed that strains with distinct molecular subtypes have persisted in
the United States and Canada for at least 25 years. These strains are
endemic rather than imported from countries with current endemic or
epidemic diphtheria.
In the 1970s, nearly 1,300 cases of
diphtheria in the United States (5) and 444 in Canada
(3, 6, 9, 19) were reported. Since the mid-1980s, the
number of cases in both countries has declined to fewer than 50 (2, 4, 11, 20). In 1996, isolation of toxigenic
Corynebacterium diphtheriae from the blood of an American
Indian woman living in the Northern Plains region of the United States
prompted public health officials to conduct enhanced diphtheria
surveillance in the patient's community, resulting in the recovery of
10 C. diphtheriae isolates (4, 16). To assess
the similarity of the U.S. and Canadian strains and their possible
endemic persistence in North America over the past 25 years, we
molecularly characterized the U.S. surveillance isolates from 1996, isolates from the same geographic region collected approximately 20 years earlier, and isolates from Ontario obtained from 1958 to 1998.
Isolates. (i) U.S. isolates.
Detailed information regarding
the U.S. surveillance and archival isolates is provided by Popovic et
al. (16). Thirty-three isolates were included in this
study: a single isolate from the blood culture of the index patient, 10 isolates recovered from the subsequent enhanced diphtheria
surveillance, 17 archival isolates collected from diphtheria patients
and carriers in South Dakota from 1973 to 1983, and 5 archival isolates
from four other states (Table 1).
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.4.1586-1590.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Persistence of a Distinct Corynebacterium
diphtheriae Clonal Group within Two Communities in the United
States and Canada Where Diphtheria Is Endemic
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
TABLE 1.
Characteristics of C. diphtheriae strains
isolated in the United States and Canada from 1973 to 1998
(ii) Canadian isolates. Twenty C. diphtheriae strains isolated from 1958 to 1998 from patients in Ontario with upper respiratory tract infections were assayed.
Identification and biotyping were performed according to current World Health Organization recommendations (10). All strains were stored in sterile defibrinated sheep blood at
70°C until needed.
Toxigenicity status. The Elek test was performed on all strains as previously described (10).
PCR for detection of the diphtheria toxin gene, tox. All isolates were assayed by PCR for the presence of both the A and B subunits of the tox gene (15).
Molecular subtyping. (i) Ribotyping. DNA was extracted from all 53 isolates using the Puregene DNA isolation kit (Gentra Systems, Inc, Minneapolis, Minn.) according to the manufacturer's instructions. Subsequent ribotyping steps were performed as previously described (16).
(ii) RAPD. All isolates were subjected to random amplified polymorphic DNA (RAPD) analysis as previously described (16). All strains were assayed using primer 3 provided in the Ready-to-Go RAPD kit (Pharmacia Biotech, Piscataway, N.J.).
(iii) MEE. Forty-six of the isolates were assayed by multilocus enzyme electrophoresis (MEE) as previously described (17).
Results and discussion. Among the U.S. surveillance and archival isolates, 20 were biotype mitis, 11 were biotype gravis, and 2 were biotype intermedius (Table 1).
Among the Canadian isolates, seven were biotype belfanti, six were biotype mitis, six were biotype gravis, and one was biotype intermedius (Table 1). Seventeen ribotypes were identified (Table 1), 11 of which were previously described (16). A difference of one band was recognized as an individual ribotype. Two ribotypes, M11a and M11b, were shared by a large proportion of the U.S. and Canadian strains (22 of 53). Ribotype M11a was seen in four Canadian strains (from 1976 and 1977) and six U.S. strains (five from South Dakota [1973 to 1980] and one from Colorado [1978]) (Fig. 1). Twelve M11b strains were isolated both in the United States and Canada over 20 years apart (1977 to 1998) (Fig. 1).
|
|
Conclusion. Molecular characterization of the U.S. and Canadian C. diphtheriae strains indicates that they have persisted in these areas for at least 25 years and are endemic to these regions rather than having been imported from countries with current endemic or epidemic diphtheria. Despite the virtual elimination of diphtheria in the United States and Canada, toxigenic strains continue to circulate in some communities within the two countries. This long-standing circulation of toxigenic C. diphtheriae, in light of reports indicating that between 20 and 60% of some population groups, particularly adults, lack protective levels of diphtheria toxin antibodies (7, 12-14, 18), poses a potentially significant risk to public health and could result in the reemergence of diphtheria in the two countries.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Epidemic Investigations Laboratory, Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, CDC, MS G34, 1600 Clifton Rd., Atlanta, GA 30333. Phone: (404) 639-4057. Fax: (404) 639-3023. E-mail: CDK5{at}CDC.GOV.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bezjak, V. 1954. Differentation of Corynebacterium diphtheriae of the mitis type found in diphtheria and ozaena. Antonie Leeuwenhoek J. Microbiol. Serol. 20:269-271. |
| 2. |
Bisgard, K.,
I. Hardy,
T. Popovic,
P. Strebel,
M. Wharton,
R. Chen, and S. Hadler.
1998.
Respiratory diphtheria in the United States, 1980-1995.
Am. J. Public Health
88:787-791 |
| 3. | Bollegraaf, E. 1988. Diphtheria in Canada, 1977-1987. Can. Dis. Wkly. Rep. 14 (18):73-76[Medline]. |
| 4. |
Centers for Disease Control and Prevention.
1997.
Toxigenic Corynebacterium diphtheriae Northern Plains Indian community, August-October 1996.
Morbid. Mortal. Wkly. Rep.
46:506-510[Medline].
|
| 5. |
Chen, R. T.,
C. V. Broome,
R. A. Weinstein,
R. Weaver, and T. F. Tsai.
1985.
Diphtheria in United States, 1971-1981.
Am. J. Public Health
75:1393-1397 |
| 6. | Cooperman, E. M. 1977. Diphtheria: a continuing hazard. Can. Med. Assoc. J. 116:1226-1227[Medline]. |
| 7. | Crossley, K., P. Irvine, J. B. Warren, B. K. Lee, and K. Mead. 1979. Tetanus and diphtheria immunity in urban Minnesota adults. JAMA 242:2298-2300[Abstract]. |
| 8. | De Zoysa, A., A. Efstratiou, R. C. George, M. Jahkola, J. Vuopio-Varkila, S. Deshevoi, G. Tseneva, and Y. Rikushin. 1995. Molecular epidemiology of Corynebacterium diphtheriae from northwestern Russia and surrounding countries studied by using ribotyping and pulsed-field gel electrophoresis. J. Clin. Microbiol. 33:1080-1083[Abstract]. |
| 9. | Dixon, J. M. S. 1984. Diphtheria in North America. J. Hyg. 93:419-432. |
| 10. | Efstratiou, A., and P. A. Maple. 1994. WHO manual for the laboratory diagnosis of diphtheria. Reference no. ICP-EPI 038(C). World Health Organization, Geneva, Switzerland. |
| 11. | Health Canada. 1999. Canadian national report on immunization. 1998. Paediatr. Child Health 4:16C[CrossRef]. |
| 12. | Klouche, M., D. Luhmann, and H. Kirchner. 1995. Low prevalence of diphtheria antitoxin in children and adults in northern Germany. Eur. J. Clin. Microbiol. Infect. Dis. 14:682-685[CrossRef][Medline]. |
| 13. |
Koblin, B. A., and T. R. Townsend.
1989.
Immunity to diphtheria and tetanus in inner-city women of childbearing age.
Am. J. Public Health
79:1297-1298 |
| 14. | Maple, P. A., A. Efstratiou, R. C. George, N. J. Andrews, and D. Sesardic. 1995. Diphtheria immunity in UK blood donors. Lancet 345:963-965[CrossRef][Medline]. |
| 15. | Mikhailovich, V. M., V. G. Melnikov, I. K. Mazurova, I. K. Wachsmuth, J. D. Wenger, M. Wharton, H. Nakao, and T. Popovic. 1995. Application of PCR for detection of toxigenic Corynebacterium diphtheriae strains isolated during the Russian diphtheria epidemic, 1990 through 1994. J. Clin. Microbiol. 33:3061-3063[Abstract]. |
| 16. |
Popovic, T.,
C. Kim,
J. Reiss,
M. Reeves,
H. Nakao, and A. Golaz.
1999.
Use of molecular subtyping to document long-term persistence of Corynebacterium diphtheriae in South Dakota.
J. Clin. Microbiol.
37:1092-1099 |
| 17. | Popovic, T., S. Kombarova, M. Reeves, H. Nakao, I. K. Mazurova, M. Wharton, I. K. Wachsmuth, and J. D. Wenger. 1996. Molecular epidemiology of diphtheria in Russia, 1985-1994. J. Infect. Dis. 174:1064-1072[Medline]. |
| 18. |
Weiss, B. P.,
M. A. Strassburg, and J. C. Feeley.
1983.
Tetanus and diphtheria immunity in an elderly population in Los Angeles County.
Am. J. Public Health
73:802-804 |
| 19. | Young, T. K. 1984. Endemicity of diphtheria in an Indian population in Northwestern Ontario. Can. J. Public Health 75:310-313[Medline]. |
| 20. | Yuan, L., W. Lau, J. Thipphawong, M. Kasenda, F. Xie, and J. Bevilacqua. 1997. Diphtheria and tetanus immunity among blood donors in Toronto. Can. Med. Assoc. J. 156:985-990[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|